Next-Gen Yellow Fever Vaccine Hits the Mark in Mid-Stage Trial
Yellow fever outbreaks in recent years and subsequent vaccine shortages have highlighted a need for updated shots that can be produced more rapidly. To help speed production, an investigational live-attenuated yellow fever vaccine is being developed that is produced in Vero cells instead of eggs. In this randomized phase II trial, the novel yellow fever…
